Patents by Inventor Omer Tsipori

Omer Tsipori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220304766
    Abstract: Provided herein are methods for treating nephrolithiasis and protecting the urothelium and inner lining of the kidney from thermal damage during lithotripsy by use of a thermosensitive bio-adhesive hydrogel. The described method dramatically improved the efficiency and effectiveness of stone clearance compared to conventional techniques while providing protection to the urothelium from potentially damaging temperature spikes.
    Type: Application
    Filed: March 24, 2022
    Publication date: September 29, 2022
    Applicants: UROGEN PHARMA LTD., The Regents of the University of California
    Inventors: Ralph V. CLAYMAN, Pengbo Jiang, Mark Schoenberg, Omer Tsipori
  • Publication number: 20220202773
    Abstract: The invention relates in general to pharmaceutical compositions, means and methods for sustained release of therapeutic agents for local treatments. It relates in particular to means and methods for local treatment of cancer diseases by embedding lyophilized Mitomycin C in a slowly releasing biocompatible hydrogel applied to affected tissue.
    Type: Application
    Filed: December 9, 2021
    Publication date: June 30, 2022
    Inventors: Yulia Hionidi, Omer Tsipori, Marina Konorty
  • Publication number: 20190343805
    Abstract: Disclosed herein are topical formulations comprising about 0.001 to about 3 wt % detomidine or a salt thereof; and, a carrier that is suitable for topical administration to a subject's skin, wherein the carrier optionally comprises a water-miscible solubilizer that is present in an amount of up to 40% by weight of the formulation; wherein the formulation has a pH of 4.5 to 9, and, wherein the formulation provides prolonged, substantially non-systemic treatment for pain. Also provided are methods for providing prolonged, non-systemic treatment for pain in a subject in need thereof comprising topically administering to the subject the presently disclosed topical formulations.
    Type: Application
    Filed: January 5, 2018
    Publication date: November 14, 2019
    Inventors: Omer TSIPORI, Mark ZAMANSKY
  • Patent number: 6703424
    Abstract: The present invention relates to a dispersible pharmaceutical composition comprising a therapeutically effective amount of L-DOPA ethyl ester, a therapeutically effective amount of a decarboxylase inhibitor, a filler, a disintegrant, and a lubricant. The present invention also provides a method of preparing the pharmaceutical composition described herein.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: March 9, 2004
    Assignee: Teva Pharmaceutical Industries, Ltgd.
    Inventors: Galit Levin, Omer Tsipori
  • Publication number: 20020151589
    Abstract: The present invention relates to a dispersible pharmaceutical composition comprising a therapeutically effective amount of L-DOPA ethyl ester, a therapeutically effective amount of a decarboxylase inhibitor, a filler, a disintegrant, and a lubricant. The present invention also provides a method of preparing the pharmaceutical composition described herein.
    Type: Application
    Filed: February 25, 2002
    Publication date: October 17, 2002
    Applicant: Teva Pharmaceutical Industries, Ltd.
    Inventors: Galit Levin, Omer Tsipori